Target Gene/Pathway💬 Info on mouse-over

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	Disease ID
1	Adrenergic signaling in cardiomyocytes 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬	D00680 💬	Methylergometrine	[2] 118, 288 💬
2	Adrenergic signaling in cardiomyocytes 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬	D08207 💬	Methylergometrine	[2] 118, 288 💬
3	Adrenergic signaling in cardiomyocytes 💬	[1] ADRB2 💬	D00688 💬	Terbutaline	[1] 118 💬
4	Adrenergic signaling in cardiomyocytes 💬	[1] ADRB2 💬	D08570 💬	Terbutaline	[1] 118 💬
5	AMPK signaling pathway 💬	[1] ADRA1A 💬	D00680 💬	Methylergometrine	[2] 118, 288 💬
6	AMPK signaling pathway 💬	[1] ADRA1A 💬	D08207 💬	Methylergometrine	[2] 118, 288 💬
7	Calcium signaling pathway 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬	D00680 💬	Methylergometrine	[2] 118, 288 💬
8	Calcium signaling pathway 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬	D08207 💬	Methylergometrine	[2] 118, 288 💬
9	Calcium signaling pathway 💬	[1] ADRB2 💬	D00688 💬	Terbutaline	[1] 118 💬
10	Calcium signaling pathway 💬	[1] ADRB2 💬	D08570 💬	Terbutaline	[1] 118 💬
11	Calcium signaling pathway 💬	[1] OXTR 💬	D03008 💬	Atosiban	[1] 118 💬
12	cAMP signaling pathway 💬	[1] ADRB2 💬	D00688 💬	Terbutaline	[1] 118 💬
13	cAMP signaling pathway 💬	[1] ADRB2 💬	D08570 💬	Terbutaline	[1] 118 💬
14	cAMP signaling pathway 💬	[1] OXTR 💬	D03008 💬	Atosiban	[1] 118 💬
15	cGMP-PKG signaling pathway 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬	D00680 💬	Methylergometrine	[2] 118, 288 💬
16	cGMP-PKG signaling pathway 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬	D08207 💬	Methylergometrine	[2] 118, 288 💬
17	cGMP-PKG signaling pathway 💬	[1] ADRB2 💬	D00688 💬	Terbutaline	[1] 118 💬
18	cGMP-PKG signaling pathway 💬	[1] ADRB2 💬	D08570 💬	Terbutaline	[1] 118 💬
19	Neuroactive ligand-receptor interaction 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬	D00680 💬	Methylergometrine	[2] 118, 288 💬
20	Neuroactive ligand-receptor interaction 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬	D08207 💬	Methylergometrine	[2] 118, 288 💬
21	Neuroactive ligand-receptor interaction 💬	[1] ADRB2 💬	D00688 💬	Terbutaline	[1] 118 💬
22	Neuroactive ligand-receptor interaction 💬	[1] ADRB2 💬	D08570 💬	Terbutaline	[1] 118 💬
23	Neuroactive ligand-receptor interaction 💬	[1] OXTR 💬	D03008 💬	Atosiban	[1] 118 💬
24	Oxytocin signaling pathway 💬	[1] OXTR 💬	D03008 💬	Atosiban	[1] 118 💬
25	Regulation of lipolysis in adipocytes 💬	[1] ADRB2 💬	D00688 💬	Terbutaline	[1] 118 💬
26	Regulation of lipolysis in adipocytes 💬	[1] ADRB2 💬	D08570 💬	Terbutaline	[1] 118 💬
27	Renin secretion 💬	[1] ADRB2 💬	D00688 💬	Terbutaline	[1] 118 💬
28	Renin secretion 💬	[1] ADRB2 💬	D08570 💬	Terbutaline	[1] 118 💬
29	Salivary secretion 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬	D00680 💬	Methylergometrine	[2] 118, 288 💬
30	Salivary secretion 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬	D08207 💬	Methylergometrine	[2] 118, 288 💬
31	Salivary secretion 💬	[1] ADRB2 💬	D00688 💬	Terbutaline	[1] 118 💬
32	Salivary secretion 💬	[1] ADRB2 💬	D08570 💬	Terbutaline	[1] 118 💬
33	Vascular smooth muscle contraction 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬	D00680 💬	Methylergometrine	[2] 118, 288 💬
34	Vascular smooth muscle contraction 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬	D08207 💬	Methylergometrine	[2] 118, 288 💬

Back to top